barr 956
Pill imprint barr 956 has been identified as Dextroamphetamine sulfate 15 mg.
Dextroamphetamine is used in the treatment of adhd; narcolepsy; sexual dysfunction, ssri induced; fatigue; hypersomnia and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy.
Dextroamphetamine 15 mg has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.
See also related documents.
Dextroamphetamine sulfate Images
- Imprint:
-
barr
956 - Strength:
- 15 mg
- Color:
- Brown
- Size:
- 16.00 mm
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
dibutyl sebacate
ethylcelluloses
methylcellulose (15 mPa.s)
povidone
propylene glycol
sucrose
corn starch
magnesium silicate
ferrosoferric oxide
gelatin
ferric oxide red
titanium dioxide
ferric oxide yellow
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
aluminum oxide
shellac
- Drug Class:
- CNS stimulants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Manufacturer:
- Barr Laboratories, Inc.
- National Drug Code (NDC):
- 00555-0956
More Dextroamphetamine Sulfate resources
- Dextroamphetamine (Wolters Kluwer)
- Dextroamphetamine Solution (Wolters Kluwer)
- Dextroamphetamine Sustained-Release Capsules (Wolters Kluwer)
- dextroamphetamine (Cerner Multum)
- dextroamphetamine (Micromedex) - Includes Dosage Information
- Dextroamphetamine (AHFS DI)
- Dextroamphetamine Sulfate (AHFS DI)
- Dextroamphetamine (FDA)
- Dextroamphetamine ER (FDA)
- Dextroamphetamine Extended-Release Capsules (FDA)
- Dextroamphetamine Sulfate (Wolters Kluwer)


